December 20, 2024 07:00 AM EST

Tracer Biotechnologies raises $10M, partners with AstraZeneca

Jared Whitlock

Features Editor

Tracer Biotechnologies has raised a $10 million Series A round to advance its technology that’s designed to monitor circulating tumor DNA in cancer patients over …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Tracer Biotechnologies raises $10M, partners with AstraZeneca

Jared Whitlock

Features Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Sage sues Biogen days after $469M buyout offer

Sionna and Odyssey end JPM week with IPO filings

Another US biotech emerges with drug candidate from China-based Keymed

FDA approves AstraZeneca and Daiichi Sankyo’s ADC for breast cancer despite lack of survival benefit

Ozempic makes list for next round of Medicare drug price negotiations

Fueling More Breakthroughs: Manufacturing Innovation to Expand Gene Therapy’s Reach

Trac­er Biotech­nolo­gies rais­es $10M, part­ners with As­traZeneca

Features Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Tracer Biotechnologies raises $10M, partners with AstraZeneca